Findings from Catholic University Louvain (UCLouvain) in Factor Xa Inhibitors Reported (In vitro assessment of the risk of ABCB1-mediated drug-drug interaction between rivaroxaban and tacrolimus in human embryonic kidney 293 recombinant cell ...)

Presse/Médias: Commentaire d'expert

période26 août 2024

Couverture médiatique

1

Couverture médiatique

  • titreFindings from Catholic University Louvain (UCLouvain) in Factor Xa Inhibitors Reported (In vitro assessment of the risk of ABCB1-mediated drug-drug interaction between rivaroxaban and tacrolimus in human embryonic kidney 293 recombinant cell ...)
    Media name / outletNewsRx Drug Daily
    Pays/TerritoireÉtats-Unis
    la date26/08/24
    PersonnesLionel Pochet
Afficher tout 1
Afficher moins

Contenu connexe